Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chlorhexidine and/or metronidazole pre-treatment with FB301 for bacterial vaginosis; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine (chlorhexidine)
  • FB301
  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Freya Biosciences ApS | Conditions: Bacterial Vaginosis (BV) | Phase 2 | Status: NOT_YET_RECRUITING